The company's net sales increased 5 per cent at Rs 24.53 crore in the June quarter as against Rs 23.30 crore in the same quarter last year, a company statement said here.
For the financial year 2014-15, the company reported revenue of Rs 90.04 crore with a net profit of Rs 14.58 crore.
"The company has received the manufacturing licence for two additional poultry vaccines - Salmonella live vaccine and IBH inactivated vaccine. These two put together would contribute Rs 2 crore sales in this financial year," Hester Biosciences CEO and MD Rajiv Gandhi said.